Article
Fluvoxamine maleate ameliorates Alzheimer disease pathology by mitigating amyloid-beta load and neuroinflammation in 5XFAD mice
2023-12-18
Abstract excerpt
<h4>Background</h4> Alzheimer pathology (AD) is accompanied by the deposition of amyloid beta (Aβ) and chronic neuroinflammation, where NLRP3 inflammasome is particularly involved. In this study, we found that the OCD drug fluvoxamine maleate (FXN) can potently ameliorate AD pathology in 5XFAD mice by autophagy-mediated clearance of Aβ and inhibition of NLRP3 inflammasome. <h4>Methods</h4> We used mice primary a...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ea49e043-959b-5020-b23b-2f1f968576c2
- DOI
- 10.1101/2023.12.17.572086
